Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Drug Name | OPB-201 |
| Trade Name | |
| Synonyms | OPB201|OPB 201 |
| Drug Descriptions |
OPB-201 comprises autologous T-lymphocytes engineered to express a T-cell receptor (TCR) targeting PRAME, which potentially induces an anti-tumor immune response (NCI Thesaurus). |
| DrugClasses | |
| CAS Registry Number | NA |
| NCIT ID | C227798 |
| Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
|---|---|---|---|
| OPB-201 | OPB-201 | 0 | 1 |